CB
CBWTF.US Auxly Cannabis Group Inc
- Market cap
- USD 261M
- P/E
- 14.9x
- P/B
- 2.01x
- ROE
- 12.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is CBWTF.US undervalued?
Graham numberCBWTF.US trades 15.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Auxly Cannabis Group Inc fundamental analysis
No fundamental analysis for Auxly Cannabis Group Inc yet.
Auxly Cannabis Group Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Auxly Cannabis Group Inc
Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. The company offers dried and fresh cannabis, plants, seeds, and oils; and edibles, extracts, and topicals under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesal…
Full company profileAuxly Cannabis Group Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Auxly Cannabis Group Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 231K | 1.38M | 747K | 8.35M | 50.8M | 83.8M | 94.5M | 101M | 122M | 151M | 171M |
| Gross Profit | 193K | 1.55M | -188K | -3.71M | 11.1M | 19.3M | 16.5M | 21.3M | 59.9M | 86.7M | 84.3M |
| Operating Income | -359K | -16.6M | -50.6M | -62.6M | -47.1M | -38.9M | -49.0M | -25.9M | 14.7M | 32.7M | 26.8M |
| EBITDA | - | -16.6M | -56.0M | -98.9M | -65.7M | -18.3M | -94.8M | -10.9M | 24.4M | 50.3M | 38.5M |
| Net Income | -230K | -18.2M | -67.0M | -103M | -85.4M | -33.7M | -130M | -44.5M | -16.3M | 41.9M | 22.3M |
| EPS | - | -0.07 | -0.12 | -0.16 | -0.12 | -0.04 | -0.13 | -0.04 | -0.17 | 0.43 | 0.22 |
| Balance Sheet | |||||||||||
| Total Assets | 417K | 92.6M | 461M | 412M | 379M | 450M | 332M | 262M | 262M | 272M | 276M |
| Total Liabilities | 33.0K | 29.8M | 140M | 150M | 187M | 242M | 246M | 211M | 146M | 94.1M | 90.6M |
| Shareholders' Equity | 384K | 62.8M | 321M | 262M | 192M | 208M | 85.7M | 51.0M | 116M | 178M | 186M |
| Cash & Short-term Investments | 0.00 | 0.00 | 0.00 | 44.1M | 21.2M | 14.8M | 14.6M | 15.6M | 18.4M | 32.3M | 38.6M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -359K | -11.4M | -43.7M | -79.1M | -33.1M | -49.6M | -2.48M | 8.21M | 16.8M | 26.2M | 29.5M |
| Capital Expenditure | 687K | 687K | 17.5M | 34.1M | 20.6M | 378K | 9.19M | 1.60M | 2.76M | 2.52M | 2.42M |
| Free Cash Flow | - | -23.2M | -61.7M | -117M | -53.9M | -50.0M | -11.7M | 6.61M | 14.0M | 23.7M | 27.1M |
| Ratios | |||||||||||
| ROE | -59.8% | -28.9% | -20.9% | -39.2% | -44.6% | -16.2% | -152.1% | -87.2% | -14.1% | 23.6% | 12.0% |
| ROA | -55.1% | -19.6% | -14.5% | -24.9% | -22.5% | -7.5% | -39.3% | -17.0% | -6.3% | 15.4% | 8.1% |
| Net Profit Margin | -99.3% | -1,319.1% | -8,967.6% | -1,228.1% | -168.2% | -40.2% | -137.9% | -44.0% | -13.4% | 27.6% | 13.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Auxly Cannabis Group Inc dividends
Auxly Cannabis Group Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:14 on Jul 28, 2026.
Who owns Auxly Cannabis Group Inc
- Insiders 23.09%
- Institutions 0.56%
- Public & others 76.35%
- Shares outstanding 103M
- Free float 78.6M
Auxly Cannabis Group Inc company profile
- Company name
- Auxly Cannabis Group Inc
- Ticker
- CBWTF.US
- ISIN
- CA05335P1099
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 446
- Fiscal year end
- December
- Address
- 777 Richmond Street West, Toronto, ON, Canada, M6J 0C2
- Phone
- 833-695-2414
- Website
- auxly.com
About Auxly Cannabis Group Inc
Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. The company offers dried and fresh cannabis, plants, seeds, and oils; and edibles, extracts, and topicals under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is headquartered in Toronto, Canada.
Auxly Cannabis Group Inc management
7- Mr. Hugo M. AlvesCEO & Director · born 1972
- Mr. Michael David LickverPresident · born 1985
- Mr. Travis WongChief Financial Officer
- Mr. Vladimir KlacarSenior Vice President of Operations · born 1989
- Mr. Ronald FichterGeneral Counsel & Corporate Secretary
- Mr. Kevin FuretChief Cultivation & Genetics Officer
- Mr. Andrew MacMillanSenior Vice President of Commercial